USPTO 2015–2025 USPTO PatentsView US Corporation

Neuroenhancement Lab, Llc

USPTO PatentsView assignee record - 8 granted patents across 12 technology areas, active 2022–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

26.4

Avg claims per patent

5-year filing velocity

The verdict

Neuroenhancement holds 8 US patents across 12 technology areas, rank #32,660 of 50,000 tracked assignees.

#32,660
of 50,000 US assignees by volume: Top 7%
by Innovation Score (54.8/100): 26.4
avg claims per patent

Portfolio overview

Neuroenhancement Lab, Llc has been granted 8 US utility patents between 2022 and 2023, placing Neuroenhancement Lab, Llc at rank #32,660 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 26.4 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Neuroenhancement Lab, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Neuroenhancement sits between Neureality Ltd. (8 patents, rank #32,656) and Nevion Europe AS (8 patents, rank #32,664) - the closest US assignees by grant volume. The composite Innovation Score of 54.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2022 through 2023, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Neuroenhancement Lab, Llc's 26.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Neuroenhancement Lab, Llc against peers pursuing similar technology classes.

Neureality

8
Neuralytix

8
Neuroenterprises

8
Neurovasc

8
Neurostim Solutio…

8
Neurotech USA

8
Nevada Naturals

8
Nevion Europe AS

8
Neuroenhancement… ◀

8

What this shows Neuroenhancement holds 8 patents at rank #32,660, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neuroenhancement

By rank, the assignees closest to #32,660 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Neuroenhancement's primary technology class.

Neuroenhancement's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Neuroenhancement Lab, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	6	75.0%
2023	2	25.0%

Which technologies does Neuroenhancement Lab, Llc patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 8

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 8

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 8

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 7

G06F - ELECTRIC DIGITAL DATA PROCESSING 5

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 4

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 2

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 1

G10H - ELECTROPHONIC MUSICAL INSTRUMENTS; INSTRUMENTS IN WHICH THE TONES ARE GENERATED BY ELECTROMECHANICAL MEANS OR ELECTRONIC GENERATORS, OR IN WHICH THE TONES ARE SYNTHESISED FROM A DATA STORE 1

H04R - LOUDSPEAKERS, MICROPHONES, GRAMOPHONE PICK-UPS OR LIKE ACOUSTIC ELECTROMECHANICAL TRANSDUCERS; DEAF-AID SETS; PUBLIC ADDRESS SYSTEMS 1

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 1

G01T - MEASUREMENT OF NUCLEAR OR X-RADIATION 1

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Where it ranks

Overall rank by patents

#32,660

Across all tracked assignees

Innovation Score

54.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Neuroenhancement Lab, Llc hold?

Neuroenhancement Lab, Llc holds 8 US granted patents filed between 2022 and 2023, spanning 12 technology areas.

What is Neuroenhancement Lab, Llc's Innovation Score?

Neuroenhancement Lab, Llc has an Innovation Score of 54.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neuroenhancement Lab, Llc focus on?

Neuroenhancement Lab, Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 8 patents. The company has filed patents in 12 CPC subclasses total.

Is Neuroenhancement Lab, Llc's patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Neuroenhancement Lab, Llc.

What does claim depth mean for Neuroenhancement Lab, Llc's patents?

Neuroenhancement Lab, Llc's patents average 26.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Neuroenhancement Lab, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Neuroenhancement's 8 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Neuroenhancement ranks #32,660 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.